August 18, 2009 (FinancialWire) — PharmAthene, Inc. (AMEX: PIP) (Current Market Cap: $79.33 Mil.) has named Charles A. Reinhart as senior vice president and chief financial officer, with responsibility for overseeing the company’s accounting and finance functions, human resources and information technology.

Christopher C. Camut, who held the position of VP and CFO of PharmAthene since January 2007, has been appointed to the newly created position of VP of government contracting and special projects.

Prior to joining PharmAthene, Reinhart served as SVP of finance and corporate strategy, and was a member of the operating leadership team of Millennium Pharmaceuticals, where he was responsible for all aspects of the company’s finance and strategic sourcing functions.

Before that, Reinhart was VP of finance at Cephalon.

Annapolis, Maryland-based PharmAthene develops and commercializes medical countermeasures against biological and chemical weapons.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.